U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H18N2.ClH
Molecular Weight 238.756
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LERIMAZOLINE HYDROCHLORIDE

SMILES

Cl.CC1=CC(C)=C(CC2=NCCN2)C(C)=C1

InChI

InChIKey=PPDOMMDYAGCCGF-UHFFFAOYSA-N
InChI=1S/C13H18N2.ClH/c1-9-6-10(2)12(11(3)7-9)8-13-14-4-5-15-13;/h6-7H,4-5,8H2,1-3H3,(H,14,15);1H

HIDE SMILES / InChI
Molecular Formula C13H18N2
Molecular Weight 202.2954
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 12:29:21 UTC 2023
Edited
by admin
on Sat Dec 16 12:29:21 UTC 2023
Record UNII
PG85ABA8RC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LERIMAZOLINE HYDROCHLORIDE
Common Name English
1H-IMIDAZOLE, 4,5-DIHYDRO-2-((2,4,6-TRIMETHYLPHENYL)METHYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
TRIMAZOLINE HYDROCHLORIDE
Systematic Name English
Lerimazoline hydrochloride [WHO-DD]
Common Name English
4,5-DIHYDRO-2-((2,4,6-TRIMETHYLPHENYL)METHYL)-1H-IMIDAZOLE MONOHYDROCHLORIDE
Systematic Name English
Code System Code Type Description
PUBCHEM
3016907
Created by admin on Sat Dec 16 12:29:22 UTC 2023 , Edited by admin on Sat Dec 16 12:29:22 UTC 2023
PRIMARY
EPA CompTox
DTXSID60203171
Created by admin on Sat Dec 16 12:29:22 UTC 2023 , Edited by admin on Sat Dec 16 12:29:22 UTC 2023
PRIMARY
SMS_ID
100000183712
Created by admin on Sat Dec 16 12:29:22 UTC 2023 , Edited by admin on Sat Dec 16 12:29:22 UTC 2023
PRIMARY
ECHA (EC/EINECS)
259-298-8
Created by admin on Sat Dec 16 12:29:22 UTC 2023 , Edited by admin on Sat Dec 16 12:29:22 UTC 2023
PRIMARY
CAS
54707-83-4
Created by admin on Sat Dec 16 12:29:22 UTC 2023 , Edited by admin on Sat Dec 16 12:29:22 UTC 2023
PRIMARY
FDA UNII
PG85ABA8RC
Created by admin on Sat Dec 16 12:29:22 UTC 2023 , Edited by admin on Sat Dec 16 12:29:22 UTC 2023
PRIMARY
Related Record Type Details
Structure of LERIMAZOLINE
PARENT -> SALT/SOLVATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966